ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Randomized, double-blind, placebo-controlled, phase I study of the safety and pharmacokinetics of namilumab in healthy Japanese and Caucasian men
International Journal of Clinical Pharmacology and Therapeutics
◽
10.5414/cp203235
◽
2018
◽
Vol 56
(11)
◽
pp. 507-517
◽
Cited By ~ 1
Author(s):
Shingo Tanaka
◽
Sayaka Harada
◽
Naoto Hiramatsu
◽
Ryou Nakaya
◽
Masaki Kawamura
Keyword(s):
Phase I
◽
Phase I Study
◽
Double Blind
◽
Double Blind Placebo
◽
Caucasian Men
Download Full-text
Related Documents
Cited By
References
Randomised, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Study of QGC001, a Centrally Acting Aminopeptidase A Inhibitor Prodrug
Clinical Pharmacokinetics
◽
10.1007/s40262-013-0125-y
◽
2013
◽
Vol 53
(4)
◽
pp. 385-395
◽
Cited By ~ 33
Author(s):
Fabrice Balavoine
◽
Michel Azizi
◽
Damien Bergerot
◽
Nadia De Mota
◽
Rémi Patouret
◽
...
Keyword(s):
Phase I
◽
Phase I Study
◽
Double Blind
◽
Double Blind Placebo
◽
Aminopeptidase A
◽
Aminopeptidase A Inhibitor
◽
Dose Escalating
Download Full-text
First-in-human safety, tolerability, and pharmacokinetics of ammoxetine in healthy subjects: a randomized, double-blind, placebo-controlled phase I study
European Journal of Pharmaceutical Sciences
◽
10.1016/j.ejps.2021.105724
◽
2021
◽
Vol 159
◽
pp. 105724
Author(s):
Qi Shen
◽
Chao Hu
◽
Jia Miao
◽
Junxia Chen
◽
Yueying Peng
◽
...
Keyword(s):
Phase I
◽
Healthy Subjects
◽
Phase I Study
◽
Double Blind
◽
Double Blind Placebo
◽
Human Safety
Download Full-text
Pharmacokinetics, Safety, and Tolerability of Intravenous Felbinac Trometamol in Healthy Chinese Volunteers: A First-in-Human Single- and Multiple-Dose Escalation Phase I Study with a Randomized, Double-Blind, Placebo-Controlled Design
CNS Drugs
◽
10.1007/s40263-020-00739-z
◽
2020
◽
Vol 34
(8)
◽
pp. 867-877
Author(s):
Min Wu
◽
Cuiyun Li
◽
Hong Zhang
◽
Jixuan Sun
◽
Xiaoxue Zhu
◽
...
Keyword(s):
Phase I
◽
Dose Escalation
◽
Phase I Study
◽
Multiple Dose
◽
Double Blind
◽
Double Blind Placebo
◽
Healthy Chinese
Download Full-text
NXY-059 Does Not Affect Bleeding Time in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, 3-Period Crossover Phase I Study
The Journal of Clinical Pharmacology
◽
10.1177/0091270006293752
◽
2007
◽
Vol 47
(2)
◽
pp. 264-272
◽
Cited By ~ 4
Author(s):
Dag Nilsson
◽
Johan Wemer
◽
Yi-Fang Cheng
◽
Ingalill Reinholdsson
◽
Gunnar Englund
◽
...
Keyword(s):
Phase I
◽
Healthy Volunteers
◽
Phase I Study
◽
Bleeding Time
◽
Double Blind
◽
Double Blind Placebo
◽
Crossover Phase
Download Full-text
Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: A dose—block-randomized, double-blind, placebo-controlled, ascending single-dose, phase I study
Clinical Therapeutics
◽
10.1016/j.clinthera.2008.10.013
◽
2008
◽
Vol 30
(10)
◽
pp. 1817-1830
◽
Cited By ~ 32
Author(s):
Kyoung Soo Lim
◽
Jung-Ryul Kim
◽
Yun-Jung Choi
◽
Kwang-Hee Shin
◽
Kyu-Pyo Kim
◽
...
Keyword(s):
Single Dose
◽
Phase I
◽
Phase I Study
◽
Dipeptidyl Peptidase
◽
Dipeptidyl Peptidase Iv
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Safety profile of the SQ house dust mite sublingual immunotherapy-tablet in Japanese adult patients with house dust mite-induced allergic asthma: a randomized, double-blind, placebo-controlled phase I study
Journal of Asthma
◽
10.1080/02770903.2018.1541353
◽
2018
◽
Vol 56
(12)
◽
pp. 1347-1355
◽
Cited By ~ 3
Author(s):
Kazuhiro Okamiya
◽
Hisakuni Sekino
◽
Ryuji Azuma
◽
Minoru Kudo
◽
Miyuki Sakaguchi
◽
...
Keyword(s):
Phase I
◽
House Dust
◽
House Dust Mite
◽
Safety Profile
◽
Phase I Study
◽
Sublingual Immunotherapy
◽
Japanese Adult
◽
Double Blind
◽
Double Blind Placebo
◽
Dust Mite
Download Full-text
Sa1767 - Eb8018, a Novel Fimh Blocker is well Tolerated in a Randomized, Double-Blind, Placebo -Controlled Phase I Study in Healthy Volunteers
Gastroenterology
◽
10.1016/s0016-5085(18)31591-9
◽
2018
◽
Vol 154
(6)
◽
pp. S-387
Author(s):
Jaikrishna Patel
◽
Jean-Michel Paillarse
◽
Patricia Françon
◽
Arnaud Laveissière
◽
Christophe Bonny
◽
...
Keyword(s):
Phase I
◽
Healthy Volunteers
◽
Phase I Study
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.2997965.2675063
◽
2010
◽
Author(s):
Johann Gudjonsson
Keyword(s):
Monoclonal Antibody
◽
Phase I
◽
Phase I Study
◽
Interferon Alfa
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti–interferon-alfa monoclonal antibody, in subjects with chronic psoriasis
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2009.05.042
◽
2010
◽
Vol 62
(3)
◽
pp. 427-436
◽
Cited By ~ 51
Author(s):
Robert Bissonnette
◽
Kim Papp
◽
Catherine Maari
◽
Yihong Yao
◽
Gabriel Robbie
◽
...
Keyword(s):
Monoclonal Antibody
◽
Phase I
◽
Phase I Study
◽
Interferon Alfa
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Safety, tolerability, pharmacokinetics, and food effect of baicalein tablets in healthy Chinese subjects: A single-center, randomized, double-blind, placebo-controlled, single-dose phase I study
Journal of Ethnopharmacology
◽
10.1016/j.jep.2021.114052
◽
2021
◽
Vol 274
◽
pp. 114052
Author(s):
Ruihua Dong
◽
Lijun Li
◽
Hongzhi Gao
◽
Kun Lou
◽
Hongmei Luo
◽
...
Keyword(s):
Single Dose
◽
Phase I
◽
Phase I Study
◽
Food Effect
◽
Single Center
◽
Double Blind
◽
Double Blind Placebo
◽
Healthy Chinese
◽
Chinese Subjects
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close